Metraipolis › archive › dc_7fff0984747e

Guiding point-of-care therapeutic drug monitoring through structure-toxicity principles — Europe PMC PMID:42394794

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42394794
DOI
10.1039/d6sc03923e
License (as archived)
solo-consultazione
Archived
2026-10-18T12:12:30.110Z
SHA-256 of the archived text
e29e0d7237d731842e58684ef2b5cbadcb1073440c95706fb0a73d91efd48848
Stable URL of this page
https://metraipolis.com/documento/dc_7fff0984747e

How to cite

Guiding point-of-care therapeutic drug monitoring through structure-toxicity principles — Europe PMC PMID:42394794 — Europe PMC (en), https://europepmc.org/article/MED/42394794 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7fff0984747e (Metraipolis archive dc_7fff0984747e, sha256 e29e0d7237d731842e58684ef2b5cbadcb1073440c95706fb0a73d91efd48848)
BibTeX
@misc{dc7fff0984747e,
  title = {Guiding point-of-care therapeutic drug monitoring through structure-toxicity principles — Europe PMC PMID:42394794},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42394794},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7fff0984747e; sha256 e29e0d7237d731842e58684ef2b5cbadcb1073440c95706fb0a73d91efd48848},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42394794. Agents can read the archived copy with the MCP tool read_document.